AstraZeneca weighing bid for Mereo BioPharma: Report

Today 3:44 AM ET (MarketWatch)

AstraZeneca (AZN.LN) is considering a bid for London-based, U.S.-listed biotech Mereo BioPharma (MREO), The Times reported without attribution. AstraZeneca already is a partner of Mereo, and the report said it may face competition from another of the cancer and rare disease specialist’s partners, which include Novartis (NOVN.EB), OncXerna and Ultragenyx (RARE).

https://www.marketwatch.com/story/astrazeneca-weighing-bid-for-mereo-biopharma-report-2022-06-17

Signup today for free and be the first to get notified of breaking news.

SIGN UP FOR OUR NEWSLETTER

Sign up for Breaking Alerts, our newsletter putting timely and updated stock and crypto markets news into your hands.

Add New Playlist